Articles about Biotech – Page 2 of 8

Podcast

Report: Life sciences sector is booming as companies swoop up lab space and raise gobs of cash

It’s hard for life sciences startups to find lab space, and there’s a good reason. The sector has been on… Read More

Chinook Therapeutics helps form China-based biotech venture to treat kidney disease

The news: Chinook Therapeutics on Tuesday announced the formation of SanReno Therapeutics, which will advance therapies for kidney disease in… Read More

Biotech company Absci, which recently went public, cuts ribbon on new HQ in Vancouver, Wash.

Absci cut the ribbon on its new headquarters in Vancouver, Wash., on Tuesday, barely three months after going public in… Read More

How pandemic-driven talent migration will change where biotech companies are located

Joel Marcus’ fortunes have risen with those of the life sciences industry. The executive chairman of life sciences builder Alexandria… Read More

Podcast

Biotech boom: How life sciences emerged from ‘the doldrums’ in Seattle and Washington state

Leslie Alexandre has seen a lot from her perch surveying Washington state’s life sciences landscape. She is set to retire… Read More

Alpine raises $91M to fuel the Seattle biotech’s clinical trials for lupus and cancer

Alpine Immune Sciences will move a potential treatment for immune conditions into human testing and support its ongoing trials for… Read More

These biotech and life sciences CEOs made the leap from software startups — here’s how they did it

In the past several years the barriers between tech and the life sciences have begun to dissolve. AI and machine… Read More

Biotech companies fuel IPO boom in Washington state over the past year

In a region better known for its tech startups and legions of software engineers, it’s biotech companies that have helped… Read More

New 130K square-foot drug manufacturing plant in Seattle area will develop COVID-19 therapeutics

The Seattle area is home to a new nimble drug manufacturing facility built by Just – Evotec Biologics that was… Read More

Seattle biotech vet Justine Dell’Aringa sees parallels in science while building her own home

At home and at work, Justine Dell’Aringa is up for a challenge. The scientific associate director of Translational Research for… Read More

Absci shares spike 30% in IPO debut, valuing Washington state biotech company at nearly $2B

Shares of Absci surged more than 30% on Thursday as the Vancouver, Wash.-based biotech company made its debut as a… Read More

Seattle-based Shape Therapeutics raises $112M to develop RNA-editing and gene therapies

Shape Therapeutics, a Seattle preclinical stage biotech company developing RNA editing and gene therapy technologies, has raised $112 million. The… Read More

Immunotherapy startup Umoja lands $210M, less than a year after raising $53M

New funding: Just seven months after announcing a $53 million Series A round, Umoja Biopharma has raised an additional $210… Read More

Oisín raises $5M to develop treatments for ‘zombie cells’ associated with age-related diseases

New funding: Seattle biotech startup Oisín Biotechnologies has raised a $5 million seed round. It’s currently developing preclinical therapies that… Read More

Grandson of Jonas Salk raises cash to find ‘genetic needles in the haystack’

New funding: Gene-sequencing startup TwinStrand Biosciences raised $50 million in a Series B round led by Section 32, a California-based… Read More

Univ. of Wash.-spinout Icosavax raises $100M to fund vaccine development technology

New funding: At a moment when vaccines are on everyone’s mind, a Seattle-based biotech company that has an unusual approach… Read More

Seattle biotech startup Outpace Bio raises $30M to fight cancer with custom-designed proteins

New funding: Outpace Bio raised a $30 million Series A investment round to design custom cell and gene-based therapies. The… Read More

Led by former Juno and Alder exec, Seattle neurology startup Eliem Therapeutics raises $80M

New funding: Eliem Therapeutics, a new Seattle biotech startup led by former Juno Therapeutics exec Bob Azelby, raised $80 million… Read More

Biotech startup AbSci raises $125M for ‘Protein Printing’ tech; total funding up to $230M

New funding: Vancouver, Wash.-based biotech company AbSci raised $125 million in a round led by Casdin Capital and Redmile Group. The… Read More

Presage Biosciences raises $13M and inks new deal with Merck for cancer drug tests

New funds, new partners: Seattle’s Presage Biosciences announced $13 million in funding as well new collaborations with biotech giant Merck… Read More

Notch Therapeutics raises $85M for cancer treatments and plans to open Seattle location

New funding: Notch Therapeutics has raised a $85 million Series A round, bringing its total funding to $91 million. The… Read More

Fred Hutch biotech spinout Ozette raises $6M from Madrona, AI2, Vulcan

New funding: Ozette, a biotech company that last year spun out of the Fred Hutchinson Cancer Research Center and was… Read More

Sana Biotechnology files to go public, looks to cure disease by modifying genes in the body

Less than three years after it was founded and with no revenue on the books, Sana Biotechnology filed to go… Read More

UW spinout Opticyte lands $4.6M to test device that quickly detects early signs of organ failure

University of Washington biotech spinout Opticyte has landed $2.9 million in federal grants and $1.7 million in seed funding. The… Read More

Well-funded stealthy biotech startup Nautilus hires former Smartsheet, Isilon, GenapSys execs

Sujal Patel is getting the band back together at his secretive new biotech startup Nautilus Biotechnology. The company is beefing… Read More

Silverback Therapeutics prices IPO at $21/share, will raise $241M in 4th Wash. state IPO of 2020

Silverback Therapeutics will raise $241.5 million as the Seattle biotech company goes public Friday. Silverback priced its IPO on Thursday… Read More

Washington State U. launches ‘Spinout Space in Spokane’ incubator for life sciences startups

Washington State University is launching a new life sciences incubator in Spokane, Wash., designed to help startups grow out of… Read More

Seattle biotech firm Umoja Biopharma raises $53M as it tackles unique approach to immunotherapy

Umoja Biopharma raised $53 million to expand development of its CAR T-cell immunotherapy treatments for blood-based and organ-based tumors in… Read More

Seattle Children’s Therapeutics leverages biotech innovation in quest for new treatments for kids

Can a nonprofit research institution operate more effectively by taking a page from the commercial biotech industry? That’s the idea… Read More